HER2 Support Group Forums - View Single Post - First-in-class antibody-drug conjugate shows significant clinical benefit against met

News · 11-08-2015, 10:14 AM

IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable,and yielded meaningful clinical activity in heavily pretreated patients with metastatic triplenegativebreast cancer...

More...

11-08-2015, 10:14 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	First-in-class antibody-drug conjugate shows significant clinical benefit against met IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable,and yielded meaningful clinical activity in heavily pretreated patients with metastatic triplenegativebreast cancer... More...